Recursion Pharmaceuticals is a company that is revolutionizing drug discovery through the use of artificial intelligence (AI). The company’s mission is to discover new drugs and to repurpose existing drugs for rare diseases. Recursion Pharmaceuticals is headquartered in Salt Lake City, Utah, and was founded in 2013 by Chris Gibson, Dean Li, and Blake Borgeson.
The traditional drug discovery process is a long and expensive process that can take years to complete. It involves identifying a target molecule, synthesizing compounds, and testing them in vitro and in vivo. This process can take up to 15 years and cost billions of dollars.